Laser photocoagulation for juxtafoveal choroidal neovascularization. Five-year results from randomized clinical trials. Macular Photocoagulation Study Group

OBJECTIVE: To summarize findings from three randomized clinical trials of krypton laser treatment of juxtafoveal neovascular lesions regarding changes in visual acuity during 5 years of follow-up, rates of persistent and recurrent choroidal neovascularization, and status of macular lesions 5 years after enrollment. DESIGN, PATIENTS, AND PRIMARY OUTCOME MEASURES: Follow-up of patients enrolled in three randomized trials of choroidal neovascularization secondary to age-related macular degeneration (AMD), ocular histoplasmosis, or idiopathic causes ended in March 1991. All patients were eligible to complete at least 3 years of follow-up examinations. Data on visual acuity, reading vision, and anatomic outcomes during 5 years of follow-up were available for 276 (92%) of 300 patients with AMD, 236 (92%) of 256 patients with ocular histoplasmosis, and 38 (97%) of 39 patients with idiopathic choroidal neovascularization enrolled 5 or more years earlier who were still living. RESULTS: Among eyes with AMD, the estimated relative risk (RR) of a loss of 6 or more lines of visual acuity from baseline to any examination from 6 months through 5 years after enrollment for untreated eyes in comparison with treated eyes was 1.20 (P = .04). Normotensive patients with AMD realized the greatest benefit from laser treatment (RR, 1.82) and hypertensive patients experienced little or no benefit (RR, 0.93). Untreated eyes with ocular histoplasmosis were at much greater risk of a 6-line decrease in visual acuity from the 1-year through the 5-year examination than were treated eyes (unadjusted RR, 2.60; RR, 4.26 after adjustment for visual acuity and hypertension at baseline; P < .001 for both). The treatment effect for eyes with idiopathic choroidal neovascularization was between the effects for eyes with AMD and eyes with ocular histoplasmosis. CONCLUSIONS: The early beneficial effects of laser treatment on visual acuity persisted for at least 5 years in eyes with all three underlying conditions. Laser treatment of similar eyes with choroidal neovascularization in a juxtafoveal location is recommended for patients with these conditions, with the caveat that hypertensive patients with AMD may fare no better with laser treatment than without treatment.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Photodynamic therapy with verteporfin in paediatric and young adult patients: long-term treatment results of choroidal neovascularisations
Lipski et al.
Br. J. Ophthalmol. 2008;92:655-660.
ABSTRACT | FULL TEXT  

Age-related macular degeneration: diagnosis and management
Cook et al.
Br Med Bull 2008;85:127-149.
ABSTRACT | FULL TEXT  

Foveolar Choroidal Circulation and Choroidal Neovascularization in Age-Related Macular Degeneration
Metelitsina et al.
IOVS 2008;49:358-363.
ABSTRACT | FULL TEXT  

A 76-year-old man with macular degeneration.
Arroyo
JAMA 2006;295:2394-2406.
FULL TEXT  

Effect of systemic hypertension on foveolar choroidal blood flow in age related macular degeneration.
Metelitsina et al.
Br. J. Ophthalmol. 2006;90:342-346.
ABSTRACT | FULL TEXT  

Mouse models may provide new insight into the relation between cholesterol and age related macular degeneration
Duncan
Br. J. Ophthalmol. 2005;89:1549-1551.
FULL TEXT  

Photodynamic therapy for inflammatory choroidal neovascularisation unresponsive to immunosuppression
Leslie et al.
Br. J. Ophthalmol. 2005;89:147-150.
ABSTRACT | FULL TEXT  

Surgical Removal vs Observation for Subfoveal Choroidal Neovascularization, Either Associated With the Ocular Histoplasmosis Syndrome or Idiopathic: I. Ophthalmic Findings From a Randomized Clinical Trial: Submacular Surgery Trials (SST) Group H Trial: SST Report No. 9
Submacular Surgery Trials Research Group
Arch Ophthalmol 2004;122:1597-1611.
ABSTRACT | FULL TEXT  

CAI Is a Potent Inhibitor of Neovascularization and Imparts Neuroprotection in a Mouse Model of Ischemic Retinopathy
Franklin et al.
IOVS 2004;45:3756-3766.
ABSTRACT | FULL TEXT  

A prospective study of visual function and quality of life following PDT in patients with wet age related macular degeneration
Armbrecht et al.
Br. J. Ophthalmol. 2004;88:1270-1273.
ABSTRACT | FULL TEXT  

Cost utility of photodynamic therapy for predominantly classic neovascular age related macular degeneration
Hopley et al.
Br. J. Ophthalmol. 2004;88:982-987.
ABSTRACT | FULL TEXT  

Photodynamic Therapy With Verteporfin for Subfoveal Choroidal Neovascularization in Age-Related Macular Degeneration: Results of an Effectiveness Study
Sharma et al.
Arch Ophthalmol 2004;122:853-856.
ABSTRACT | FULL TEXT  

The Complications of Age-Related Macular Degeneration Prevention Trial (CAPT): rationale, design and methodology
The Complications of Age-Related Macular Degenerat
Clin Trials 2004;1:91-107.
ABSTRACT  

Radiotherapy for recurrent choroidal neovascularisation complicating age related macular degeneration
Marcus et al.
Br. J. Ophthalmol. 2004;88:114-119.
ABSTRACT | FULL TEXT  

The Role of Adult Bone Marrow-Derived Stem Cells in Choroidal Neovascularization
Sengupta et al.
IOVS 2003;44:4908-4913.
ABSTRACT | FULL TEXT  

Induction of Angiogenic Cytokine Expression in Cultured RPE by Ingestion of Oxidized Photoreceptor Outer Segments
Higgins et al.
IOVS 2003;44:1775-1782.
ABSTRACT | FULL TEXT  

CNV subtype in first eyes predicts severity of ARM in fellow eyes
Abugreen et al.
Br. J. Ophthalmol. 2003;87:307-311.
ABSTRACT | FULL TEXT  

Age-Related Macular Degeneration
Gottlieb
JAMA 2002;288:2233-2236.
FULL TEXT  

Visual Outcomes in the Subfoveal Radiotherapy Study: A Randomized Controlled Trial of Teletherapy for Age-Related Macular Degeneration
Hart et al.
Arch Ophthalmol 2002;120:1029-1038.
ABSTRACT | FULL TEXT  

Limited macular translocation with scleral retraction suture
Sullivan et al.
Br. J. Ophthalmol. 2002;86:434-439.
ABSTRACT | FULL TEXT  

Targeting of Interferon to Choroidal Neovascularization by Use of Dextran and Metal Coordination
Yasukawa et al.
IOVS 2002;43:842-848.
ABSTRACT | FULL TEXT  

Short wavelength automated perimetry in age related maculopathy
Remky et al.
Br. J. Ophthalmol. 2001;85:1432-1436.
ABSTRACT | FULL TEXT  

Monoclonal Antibody-Mediated Drug Targeting to Choroidal Neovascularization in the Rat
Kamizuru et al.
IOVS 2001;42:2664-2672.
ABSTRACT | FULL TEXT  

Treatment of subfoveal choroidal neovascularisation in age related macular degeneration: focus on clinical application of verteporfin photodynamic therapy
SOUBRANE and BRESSLER
Br. J. Ophthalmol. 2001;85:483-495.
FULL TEXT  

Lutein and Zeaxanthin in the Diet and Serum and Their Relation to Age-related Maculopathy in the Third National Health and Nutrition Examination Survey
Marse-Perlman et al.
Am J Epidemiol 2001;153:424-432.
ABSTRACT | FULL TEXT  

External Beam Irradiation of Subfoveal Choroidal Neovascularization Complicating Age-Related Macular Degeneration: One-Year Results of a Prospective, Double-Masked, Randomized Clinical Trial
Marcus et al.
Arch Ophthalmol 2001;119:171-180.
ABSTRACT | FULL TEXT  

A New Drug-Screening Procedure for Photosensitizing Agents Used in Photodynamic Therapy for CNV
Lange et al.
IOVS 2001;42:38-46.
ABSTRACT | FULL TEXT  

Visual Outcome After Surgical Removal of Choroidal Neovascularization in Pediatric Patients
Uemura and Thomas
Arch Ophthalmol 2000;118:1373-1378.
ABSTRACT | FULL TEXT  

Extracts from "Clinical Evidence": Age related macular degeneration
Arnold and Sarks
BMJ 2000;321:741-744.
FULL TEXT  

Real time fixation point monitoring system for photocoagulation of juxtafoveal neovascularisation
Harino et al.
Br. J. Ophthalmol. 2000;84:1053-1055.
ABSTRACT | FULL TEXT  

Age-Related Macular Degeneration
Fine et al.
NEJM 2000;342:483-492.
FULL TEXT  

Angiography of Fluoresceinated Anti-Vascular Endothelial Growth Factor Antibody and Dextrans in Experimental Choroidal Neovascularization
Tolentino et al.
Arch Ophthalmol 2000;118:78-84.
ABSTRACT | FULL TEXT  

Targeted Delivery of Anti-Angiogenic Agent TNP-470 Using Water-Soluble Polymer in the Treatment of Choroidal Neovascularization
Yasukawa et al.
IOVS 1999;40:2690-2696.
ABSTRACT | FULL TEXT  

Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With Verteporfin: One-Year Results of 2 Randomized Clinical Trials--TAP Report 1
Treatment of Age-related Macular Degeneration With
Arch Ophthalmol 1999;117:1329-1345.
ABSTRACT | FULL TEXT  

Age-related Macular Degeneration and Antioxidant Status in the POLA Study
Delcourt et al.
Arch Ophthalmol 1999;117:1384-1390.
ABSTRACT | FULL TEXT  

Photodynamic Therapy With Verteporfin Is Effective for Selected Patients With Neovascular Age-related Macular Degeneration
Fine
Arch Ophthalmol 1999;117:1400-1402.
FULL TEXT  

Photodynamic Therapy With Verteporfin for Choroidal Neovascularization Caused by Age-related Macular Degeneration: Results of a Single Treatment in a Phase 1 and 2 Study
Miller et al.
Arch Ophthalmol 1999;117:1161-1173.
ABSTRACT | FULL TEXT  

Photodynamic Therapy With Verteporfin for Choroidal Neovascularization Caused by Age-related Macular Degeneration: Results of Retreatments in a Phase 1 and 2 Study
Schmidt-Erfurth et al.
Arch Ophthalmol 1999;117:1177-1187.
ABSTRACT | FULL TEXT  

Radiotherapy for isolated occult subfoveal neovascularisation in age related macular degeneration: a pilot study
Donati et al.
Br. J. Ophthalmol. 1999;83:646-651.
ABSTRACT | FULL TEXT  

Indocyanine green guided laser photocoagulation in patients with occult choroidal neovascularisation
Weinberger et al.
Br. J. Ophthalmol. 1999;83:168-172.
ABSTRACT | FULL TEXT  

Immunosuppressive Treatment of Choroidal Neovascularization Associated With Endogenous Posterior Uveitis
Dees et al.
Arch Ophthalmol 1998;116:1456-1461.
ABSTRACT | FULL TEXT  

Prophylactic laser treatment in early age related maculopathy reduced the incidence of exudative complications
Frennesson and Nilsson
Br. J. Ophthalmol. 1998;82:1169-1174.
ABSTRACT | FULL TEXT  

Smoking and Age-related Macular Degeneration: The POLA Study
Delcourt et al.
Arch Ophthalmol 1998;116:1031-1035.
ABSTRACT | FULL TEXT  

A Model of the Incidence and Consequences of Choroidal Neovascularization Secondary to Age-related Macular Degeneration: Comparative Effects of Current Treatment and Potential Prophylaxis on Visual Outcomes in High-Risk Patients
Lanchoney et al.
Arch Ophthalmol 1998;116:1045-1052.
ABSTRACT | FULL TEXT